Pharma and health care agency CMI/Compas named Paul Kallukaran as its chief analytics and insights officer as the agency intensifies its focus on digital marketing and data analytics. CMI/Compas added 51 new staff members to its 700-person firm.

A documentary about the late actor Robin Williams is being revamped by Acadia Pharmaceuticals to focus on Lewy body dementia, a form of dementia Williams unknowingly had at the end of his life. "Spark -- Robin Williams and his Battle with Lewy Body Dementia" discusses the symptoms of the disease and dementia-related psychosis.

A campaign by pharmaceutical company Kyowa Kirin for the rare genetic disease X-linked hypophosphatemia highlights the disease's effects with digital makeup created by makeup artist James Mac Inerney. Kyowa Kirin is marketing Crysvita, which received FDA approval in 2018 for patients with XLH who are 12 months and older.

Exact Sciences' Cologuard Classic tournament brought together celebrities and colon cancer survivors to emphasize the importance of screening for colon cancer. The tournament inspired more Google searches for the test, said Kevin Conroy, CEO of Exact Sciences.

Sales of tardive dyskinesia treatments such as Neurocrine's Ingrezza and Teva's Austedo are expected to surpass Wall Street projections, according to a Leerink Partners survey of 50 physicians. Fifty-three percent of TD patients are expected to be "candidates" for the drugs, an increase from a previous survey, according to the doctors surveyed.